MedPath

Comparison Between IORT and Postoperative Radiotherapy in Breast Conserving Surgery

Not Applicable
Active, not recruiting
Conditions
Quality of Life
Interventions
Radiation: intraoperative radiotherapy
Radiation: postoperative radiotherapy
Registration Number
NCT04789889
Lead Sponsor
Xiangyun Zong
Brief Summary

To compare the satisfaction with conserved breast, acute and chronic postoperative complications and tumor control between intraoperative radiotherapy(IORT) and traditional postoperative radiotherapy following breast-conserving surgery (BCS).

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Primary invasive breast cancer confirmed by pathology.
  • Maximum tumor diameter ≤3.5cm.
  • Clinical lymph nodes are negative.
  • Single or multiple tumors are located on the same side of the nipple and in the same quadrant.
  • ECOG status score ≤ 2.
  • With informed Consents.
Exclusion Criteria
  • Previous history of breast cancer or other malignant tumors.
  • Inflammatory breast cancer; 3. Previous radiotherapy history.
  • Other diseases affecting radiotherapy, such as connective tissue disease, heart disease, lung disease and so on.
  • Patients who are not going to have the axillary lymph node surgery (including SLN and ALND) were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IORTintraoperative radiotherapyintraoperative radiotherapy(IORT) in BCS.
PORTpostoperative radiotherapytraditional postoperative radiotherapy following BCS.
Primary Outcome Measures
NameTimeMethod
Rate of successful surgical procedureimmediately after surgery

the rate of successful breast conserving surgery

satisfaction with conserved breast1 month after surgery

the patients' satisfaction to postoperative breast including shape and feeling(Harvard/NSABP/RTOG BREAST COSMETIC SCALE: excellent, good, fair, poor)

Secondary Outcome Measures
NameTimeMethod
Rate of acute and chronic postoperative complications(CTCAE 3.0)1-month, 6-month after surgery

The incidence of adverse reactions at 1 and 6 months after operation

DFS2-3 years after surgery

long-term postoperative disease-free survival

OS2-3 years after surgery

long-term postoperative overall survival

Trial Locations

Locations (1)

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath